Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Galectin Therapeutic (GALT)

2.49 0.08 (3.32%)

12-13 16:00

Open:

2.39

Pre. Close:

2.41

High:

2.57

Low:

2.3876

Volume:

612,774

Market Cap:

89M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

2.59 - 2.63

2.63 - 2.71

Low:

2.23 - 2.26

2.26 - 2.35

Close:

2.39 - 2.44

2.44 - 2.57

Technical analysis  (as of: 2017-12-13 5:03:34 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 3.67     One year: 4.28

Support:

Support1: 1.99    Support2: 1.28

Resistance:

Resistance1: 3.14    Resistance2: 3.67

Pivot:

2.37

Moving Averages:

MA(5): 2.35     MA(20): 2.50

MA(100): 2.21     MA(250): 2.11

MACD:

MACD(12,26): -0.08     Signal(12,26,9): -0.07

%K %D:

%K(14,3): 65.87     %D(3): 60.58

RSI:

RSI(14): 51.42

52-Week:

High: 3.68  Low: 0.88  Change(%): 179.8

Average Vol(K):

3-Month: 60753  10-Days 222290

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
GALT has closed below upper band by 41.2%. Bollinger Bands are 114.7% wider than normal. The large width of the bands suggest high volatility as compared to GALT's normal range. The bands have been in this wide range for 9 bars. This is a sign that the current trend might continue.

Headline News

Wed, 06 Dec 2017 15:56:15 GMT
Galectin Therapeutics: Time To Exit

Mon, 11 Dec 2017 13:52:30 GMT
Galectin Therapeutics to Webcast Corporate Update at Annual Meeting of ...

Mon, 11 Dec 2017 16:52:30 GMT
Lookout for Price Target? Sigma Designs, Inc. (SIGM), Galectin Therapeutics ...

Wed, 13 Dec 2017 17:48:45 GMT
Reviewing Galectin Therapeutics (NASDAQ:GALT) and The Competition

Mon, 11 Dec 2017 18:22:30 GMT
Healthcare Stock to Buy: Galectin Therapeutics, Inc. (GALT)

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Biotechnology Medical Research

Shares Out. (M)

35.64

Shares Float (M)

28.27

% Held by Insiders

20.97

% Held by Institutions

10.75

Shares Short (K)

1090

Shares Short Prior Month (K)

1040

Stock Financials

EPS

-0.590

EPS Est. Current Year

-0.530

EPS Est. Next Year

-0.520

EPS Est. Next Quarter

-0.130

Forward EPS

-0.450

Book Value (p.s.)

-0.180

PEG Ratio

Profit Margin

Operating Margin

Return on Assets (ttm)

-104.6

Return on Equity (ttm)

-251.0

Qtrly Rev. Growth

Gross Profit (p.s.)

Sales Per Share

EBITDA (p.s.)

-0.543

Qtrly Earnings Growth

Operating Cash Flow (M)

-16.85

Levered Free Cash Flow (M)

-10.50

atoplab.com

Valuation

P/E

-4.22

P/E Growth Ratio

0.03

P/BV

-13.83

P/S

P/CF

-5.27

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

2012-03-23

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.